Company Performance Metrics
Alon Shalev: Founder, VP BD and Application Dev- Kevin Mayberry: CEO
EndoSpan is a pre-clinical stage medical device startup that develops endovascular medical devices for the treatment of aortic arch diseases, including aneurysms, dissections, and other complex vascular conditions. The company designs stent graft systems that support minimally invasive repair procedures intended to reduce the need for open-chest
surgery in selected patients. Its product portfolio includes the NEXUS and NEXUS DUO aortic arch stent graft systems, which are engineered for complex anatomical structures and endovascular access. EndoSpan also develops modular docking and fixation technologies that support graft stability, sealing performance, and procedural navigation during implantation. The company conducts clinical studies, physician training programs, and product evaluation activities related to aortic repair and vascular intervention techniques. In addition, EndoSpan collaborates with cardiovascular surgeons, interventional specialists, and healthcare organizations to support the adoption and clinical assessment of endovascular aortic repair technologies.
